Stay updated on ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell
Sign up to get notified when there's something new on the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page.

Latest updates to the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page
- CheckyesterdayChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.9%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check66 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check81 days agoChange DetectedThe page has been updated to include specific details about a new clinical trial (ANZUP1802) for non-clear cell renal cell carcinoma, including the treatment drug Cabozantinib and its study parameters. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference50%
Stay in the know with updates to ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell
Enter your email address, and we'll notify you when there's something new on the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page.